BioTime to Present at the Upcoming Ladenburg Thalmann and MicroCap Conferences Sep 27, 2018 07:00AM
BioTime, Inc. (BTX) PT Raised to $7 at Ladenburg Thalmann Aug 3, 2018 06:57AM
BioTime, Inc. Announces Closing of Public Offering and Underwriters’ Full Exercise of Over-Allotment Option Oct 17, 2017 04:05PM
BioTime (BTX) Prices 9.6M Share Common Offering at $2.60/Sh Oct 13, 2017 09:17AM
BioTime, Inc. Announces Pricing of $25.0 Million Public Offering of Common Stock Oct 13, 2017 09:15AM


Sep 26, 2017 07:03AM BioTime (BTX) Reports Positive Secondary and Additional Positive Long-Term Data from the Renevia Pivotal Trial
Sep 26, 2017 07:00AM BioTime Announces Positive Secondary and Additional Positive Long-Term Data from the Renevia® Pivotal Trial
Sep 20, 2017 07:00AM BioTime to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Jun 19, 2017 07:22AM BioTime, Inc. (BTX) PT Raised to $6.50 at Ladenburg Thalmann
Feb 15, 2017 04:05PM BioTime, Inc. Announces Closing of Public Offering of Common Stock
Feb 10, 2017 09:03AM BioTime (BTX) Prices 6.5M Common Stock Offering at $2.70/Share
Feb 10, 2017 09:02AM BioTime, Inc. Announces Pricing of Public Offering of Common Stock
Sep 23, 2016 08:03AM Ladenburg Thalmann Starts BioTime, Inc. (BTX) at Buy
Sep 23, 2016 07:00AM BioTime to Webcast Presentation at the Ladenburg Thalmann 2016 Healthcare Conference
Jul 5, 2016 11:35AM BioTime, Inc. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option
Jun 21, 2016 11:55AM BioTime, Inc. Announces Closing of Public Offering of Common Stock
Jun 16, 2016 09:56AM BioTime (BTX) Prices 7.3M Stock Offering at $2.39/Share
Jun 16, 2016 09:41AM BioTime, Inc. Announces Pricing of Public Offering of Common Stock